CSL is a global biotechnology company that consists of CSL Behring, CSL Seqirus, and CSL Vifor. Together, they work to ensure people everywhere receive the treatments they need. The company has delivered biotechnology excellence for over a century, with a diverse portfolio focused on rare and serious diseases, vaccines, and nephrology.
CSL Behring is a global biotech leader offering a broad range of biotherapies for conditions including bleeding disorders, immunodeficiencies, hereditary angioedema, and neurological disorders. CSL Seqirus is a world leader in influenza vaccine production, while CSL Vifor focuses on iron deficiency and nephrology.
